Patient-Reported Outcomes of Treatment of Opioid Dependence With Weekly and Monthly Subcutaneous Depot vs Daily Sublingual Buprenorphine

Personalizing the Treatment of Substance Use Disorders

(2020) Nora D. Volkow   AMERICAN JOURNAL OF PSYCHIATRY

Opioid use disorder

(2020) John Strang et al.   Nature Reviews Disease Primers

Classics in Chemical Neuroscience: Buprenorphine

(2020) Jillian L. Kyzer et al.   ACS Chemical Neuroscience

Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

(2019) Barbara R Haight et al.   LANCET

Management of opioid use disorder in the USA: present status and future directions

(2019) Carlos Blanco et al.   LANCET

Medications for opioid use disorders: clinical and pharmacological considerations

(2019) Nora D. Volkow et al.   JOURNAL OF CLINICAL INVESTIGATION

Global patterns of opioid use and dependence: harms to populations, interventions, and future action

(2019) Louisa Degenhardt et al.   LANCET

Weekly and Monthly Subcutaneous Buprenorphine Depot Formulations vs Daily Sublingual Buprenorphine With Naloxone for Treatment of Opioid Use Disorder

(2018) Michelle R. Lofwall et al.   JAMA Internal Medicine

Measuring quality of life in opioid-dependent people: a systematic review of assessment instruments

(2017) Lisa Strada et al.   QUALITY OF LIFE RESEARCH

Development of OSTQOL: A Measure of Quality of Life for Patients in Opioid Substitution Treatment

(2017) Lisa Strada et al.   EUROPEAN ADDICTION RESEARCH

Development of a brief tool for monitoring aberrant behaviours among patients receiving long-term opioid therapy: The Opioid-Related Behaviours In Treatment (ORBIT) scale

(2016) Briony Larance et al.   DRUG AND ALCOHOL DEPENDENCE

DEVELOPMENT AND VALIDATION OF ‘SURE’: A PATIENT REPORTED OUTCOME MEASURE (PROM) FOR RECOVERY FROM DRUG AND ALCOHOL DEPENDENCE

(2016) Joanne Neale et al.   DRUG AND ALCOHOL DEPENDENCE

Adaptation and validation of the Treatment Burden Questionnaire (TBQ) in English using an internet platform

(2014) Viet-Thi Tran et al.   BMC Medicine

World Medical Association Declaration of Helsinki

(2013)   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trial

(2013) Patrick Vermersch et al.   Multiple Sclerosis Journal

MMRM vs. LOCF: A Comprehensive Comparison Based on Simulation Study and 25 NDA Datasets

(2009) Ohidul Siddiqui et al.   Journal of Biopharmaceutical Statistics